Problem statement: Answer the multiple-choice question.
Question: Which compound exhibits a -80.206% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, c, or d without using any other words.
Options:
a. CCCCN1C(=O)CN(CCc2ccccc2)C(=O)C1c1ccc(OC)cc1
b. CCCCN(CCCC)/C(N)=N/c1nc(C)cc(C)n1
c. O=C(Cc1ccc(S(=O)(=O)N2CCOCC2)s1)NCCOc1ccccc1F
d. O=C(NCc1ccccc1)c1onc(CSc2ccc(Cl)cc2)c1C(=O)NCc1ccccc1
Answer: b. CCCCN(CCCC)/C(N)=N/c1nc(C)cc(C)n1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCCCN(CCCC)/C(N)=N/c1nc(C)cc(C)n1
CCCCN(CCCC)/C(N)=N/c1nc(C)cc(C)n1
1,1-dibutyl-2-(4,6-dimethylpyrimidin-2-yl)guanidine